Z1BH34 Stock Overview
Operates as a medical technology company worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Zimmer Biomet Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$148.08 |
| 52 Week High | US$158.25 |
| 52 Week Low | US$146.40 |
| Beta | 1.02 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -2.06% |
| 3 Year Change | n/a |
| 5 Year Change | -5.44% |
| Change since IPO | -5.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| Z1BH34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | 0% | 0.1% | 5.3% |
| 1Y | -2.1% | 1.8% | -5.1% |
Return vs Industry: Z1BH34 underperformed the BR Medical Equipment industry which returned 9.8% over the past year.
Return vs Market: Z1BH34 exceeded the BR Market which returned -9% over the past year.
Price Volatility
| Z1BH34 volatility | |
|---|---|
| Z1BH34 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.0% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in BR Market | 9.4% |
| 10% least volatile stocks in BR Market | 2.8% |
Stable Share Price: Z1BH34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine Z1BH34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1927 | 18,000 | Ivan Tornos | www.zimmerbiomet.com |
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products.
Zimmer Biomet Holdings, Inc. Fundamentals Summary
| Z1BH34 fundamental statistics | |
|---|---|
| Market cap | R$131.54b |
| Earnings (TTM) | R$6.54b |
| Revenue (TTM) | R$45.82b |
20.1x
P/E Ratio2.9x
P/S RatioIs Z1BH34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| Z1BH34 income statement (TTM) | |
|---|---|
| Revenue | US$7.60b |
| Cost of Revenue | US$2.13b |
| Gross Profit | US$5.46b |
| Other Expenses | US$4.38b |
| Earnings | US$1.08b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 06, 2025
| Earnings per share (EPS) | 5.44 |
| Gross Margin | 71.90% |
| Net Profit Margin | 14.27% |
| Debt/Equity Ratio | 53.6% |
How did Z1BH34 perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield18%
Payout RatioDoes Z1BH34 pay a reliable dividends?
See Z1BH34 dividend history and benchmarks| Zimmer Biomet Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Feb 06 2025 |
| Days until Ex dividend | 82 days |
| Days until Dividend pay date | 41 days |
Does Z1BH34 pay a reliable dividends?
See Z1BH34 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/21 07:09 |
| End of Day Share Price | 2024/10/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Zimmer Biomet Holdings, Inc. is covered by 63 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Stephan Gasteyger | Atlantic Equities LLP |
| Jeffrey Johnson | Baird |